ModivCare Capital Surpluse from 2010 to 2024

MODV Stock  USD 17.76  0.03  0.17%   
ModivCare Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse will likely drop to about 352.3 M in 2024. During the period from 2010 to 2024, ModivCare Capital Surpluse regression line of quarterly data had mean square error of 1737.2 T and geometric mean of  300,231,849. View All Fundamentals
 
Capital Surpluse  
First Reported
2011-06-30
Previous Quarter
445.4 M
Current Value
446.7 M
Quarterly Volatility
93.3 M
 
Yuan Drop
 
Covid
Check ModivCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ModivCare's main balance sheet or income statement drivers, such as Interest Expense of 72.6 M, Selling General Administrative of 289.3 M or Total Revenue of 2.9 B, as well as many indicators such as Price To Sales Ratio of 0.22, Dividend Yield of 0.0527 or PTB Ratio of 3.79. ModivCare financial statements analysis is a perfect complement when working with ModivCare Valuation or Volatility modules.
  
Check out the analysis of ModivCare Correlation against competitors.
For more information on how to buy ModivCare Stock please use our How to Invest in ModivCare guide.

Latest ModivCare's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of ModivCare over the last few years. It is ModivCare's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ModivCare's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

ModivCare Capital Surpluse Regression Statistics

Arithmetic Mean317,112,481
Geometric Mean300,231,849
Coefficient Of Variation33.07
Mean Deviation83,426,283
Median313,955,000
Standard Deviation104,869,530
Sample Variance10997.6T
Range334.7M
R-Value0.92
Mean Square Error1737.2T
R-Squared0.85
Slope21,661,619
Total Sum of Squares153966.7T

ModivCare Capital Surpluse History

2024352.3 M
2023510.9 M
2022444.3 M
2021430.4 M
2020421.3 M
2019351.5 M
2018334.7 M

About ModivCare Financial Statements

ModivCare investors use historical fundamental indicators, such as ModivCare's Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ModivCare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse510.9 M352.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ModivCare Stock Analysis

When running ModivCare's price analysis, check to measure ModivCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ModivCare is operating at the current time. Most of ModivCare's value examination focuses on studying past and present price action to predict the probability of ModivCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ModivCare's price. Additionally, you may evaluate how the addition of ModivCare to your portfolios can decrease your overall portfolio volatility.